JucaBio LLC is a clinical-stage biopharmaceutical company that acquires early-stage novel therapeutics and creates agile portfolio companies to advance them through clinical development. Operating on a hub-and-spoke model, the company serves the biopharmaceutical industry by developing high-need medical assets to value inflection points for spin-out or acquisition.
Subscribe to see JucaBio LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
JucaBio LLC is a biotechnology company headquartered in Cincinnati, United States. Its most recent funding round raised $3.8M in December 2024. Xcout tracks 12 named people at JucaBio LLC, including Catherine Pearce (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
6 more named people on record for JucaBio LLC, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $3.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of JucaBio LLC's closest competitors — see the full list of competitors and alternatives →
Jupiter Biomedical Research, Inc. is a biomedical research company founded in 2016 and located in Palm Beach Gardens, Florida. The company is focused on developing innovative drug candidates to treat serious diseases.
Lin BioScience is a clinical-stage biopharmaceutical company that discovers and develops novel, first-in-class drug candidates for the treatment of cancer, eye diseases, and metabolic diseases. The company serves patients with significant unmet medical needs through targeted therapies such as oral treatments for dry age-related macular degeneration, Stargardt disease, and acute leukemia.
Rubedo Life Sciences is a clinical-stage biopharmaceutical company headquartered in Sunnyvale and Mountain View, California, developing a broad portfolio of innovative therapies.
VivaMed BioPharma is a clinical-stage biopharmaceutical company that develops new chemical entities and repurposed drugs. It serves the healthcare and research sectors by advancing therapies across neurology, pain, psychiatry, pulmonology, and rheumatology through global partnerships and operator-led development.
ArcheNova Biotech is a global biopharmaceutical value creation platform dedicated to transforming scientific discoveries into clinically validated therapies. The company integrates breakthrough technologies to accelerate clinical development and commercial success.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about JucaBio LLC? Suggest a correction · Work at JucaBio LLC? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.